Telomeres are the capping structures of chromosome ends and are composed of repeated DNA sequences (B10 kb in adult somatic cells) and a specific set of associated proteins. The regulation of telomere length results from the action of telomerelengthening mechanisms, such as the telomerase complex (hTERT, hTR and dyskerin), and of telomere-shortening mechanisms, such as replication and recombination. Telomerase activity is regulated in cis by the shelterin hexa-protein complex (TRF1, TRF2, hRAP1, POT1, TIN2 and TPP1) and epigenetic factors. 1, 2 Proteins involved in DNA replication and repair are also associated in telomeric structure and function. 2 The shortening of telomere sequences upon cell divisions in most somatic cells results in irreversible cell growth arrest called senescence or in apoptosis. A change in telomere function is one of the main mechanisms underlying the evolution and maintenance of cancer cells. Telomere erosion may be critical in tumour suppression as it impairs cell proliferation. In many cancer cells, this is circumvented by reactivating the expression and/or activity of telomerase or by homologous recombination. 1, 2 Chronic lymphocytic leukaemia (CLL) is a B-cell malignancy with increased incidence among the elderly. The disease is due to an imbalance between cell death and proliferation resulting in an accumulation of malignant cells in the bone marrow and peripheral blood (reviewed in Van Bockstaele et al. 3 ). Clinically, the disease varies from indolent, which may progress to/or appear at diagnostic as an aggressive incurable form. The most commonly used biological markers for the disease outcome are the type of chromosomal aberration and the mutational status of immunoglobulin heavy-chain variable region genes (IgV H ), often associated with the expression status of Zap70 tyrosine kinase (reviewed in Van Bockstaele et al.
3 ). The telomere length and telomerase activity are further prognostic markers as unfavourable disease was associated with short telomeres 4 (reviewed in Van Bockstaele et al. 3 ). This, together with altered expression of several telomeric components, 5 indicates that telomeres are profoundly rearranged in CLL cells.
A subgroup of CLL cells is resistant to DNA damage-induced apoptosis in vitro (reviewed in Bouley et al. 6 ) and patients harbouring these cells inevitably develop the aggressive form of disease, suggesting that this is a clinically relevant factor. Here, we investigated whether specific telomere alterations can distinguish CLL cells sensitive (CLL-S) or resistant (CLL-R) to DNA damage-induced apoptosis in vitro. A total of 35 patients were included in this study (16 CLL-R and 19 CLL-S, clinical and biological behaviours were presented in Table 1 ). Southern blot analysis showed a significant difference in telomere length between the two subgroups of patients ( Figure 1a ). The mean telomere length was twofold shorter (U-test, Po0.001) in CLL-R compared with the CLL-S (3552 ± 1151 bp for CLL-R and 8010 ± 1668 bp for CLL-S) (Figure 1b) . Furthermore, we observed a positive correlation (R 2 ¼ 0.675) between telomere restriction fragment length and the in vitro sensitivity to apoptosis (Figure 1c ) that appeared independent of previous clinical treatment of patients (Figures 1c and d) . The use of the Spearman's rank correlation showed that this association was significant (Po0.0001). These results clearly show that resistant CLL cells have shorter telomeres than sensitive CLL cells. The mRNA level of hTERT was assessed by quantitative PCR analysis and revealed no significant difference (U-test, P40.05) between the two subgroups of patients (Figure 2a) . We also analyzed the mRNA level of the negative regulator of the telomerase, PinX1, by quantitative PCR analysis in samples already included in the analysis for the expression of hTERT. No significant difference (U-test, P40.05) was observed between the two subgroups of cells (Figure 2b ). Telomere maintenance and protection mainly depends on the presence of the six shelterin components and their stoichiometry at chromosome ends is crucial for telomere Sex was defined as male and female, and age is expressed in years. Staging was according to the Binet's staging system. Treatments (if any) were received at least 3 months before cell sampling for DNA extractions, chromatin immunoprecipitation assays and apoptosis in vitro determination. Apoptosis score was established as described. 6 The somatic mutational status of IgV H has been established according to the 98% homology cutoff value to the closest germline gene; that is, o98% homology was considered as mutated (M), whereas X98%
homology was considered as unmutated. Chromosomal aberrations were established by fluorescent in situ hybridization using LSI ATM/LSI p53 and LSI D13S319/LSI 13q34/CEP12 probe sets (Abbott, Rueil Malmaison, France), which are complementary to 11q22.3, 17p13.1, 13q14.3, 13q34 and 12p11.1-q11 genome regions, respectively. Presented data take into account the percentage of the interphase nuclei with the same chromosomal anomaly (that is, at least 5% of nuclei should contain the same aberration).
Letters to the Editor stability. 2 We determined the mRNA level of five telomeric proteins (TRF1, TRF2, TIN2, hRAP1 and POT1) using quantitative PCR analysis in CLL-R and CLL-S samples. No significant difference between the two subgroups (U-test, P40.05) was observed ( Figure 2c ). TRF2 is involved in telomeres structure and protection, whereas TRF1 is implicated in telomere length control through negative regulation of the telomerase activity. We therefore analyzed TRF2 protein levels by western blot. No significant difference (U-test, P40.05) was observed between CLL-R and CLL-S (Figure 2d) . Similarly, no significant difference (U-test, P40.05) in the levels of theses two proteins at telomeres was established by chromatin immunoprecipitation (ChlP) assays (Figure 2e) .
Telomeres have epigenetic marks characteristic of heterochromatin, including trimethylation of histone H3 lysine 9 and histone H4 lysine 20 and hypoacetylation of histone H3. In particular, decreased levels of H3K9 trimethylation at telomeres are associated with aberrant telomere elongation. 1 To determine whether telomeric chromatin may be discriminating between resistant and sensitive CLL cells, we have analyzed histone H3K9 methylation (H3K9me3) and acetylation (H3K9ac) at telomeres of B-CLL cells by chromatin immunoprecipitation Letters to the Editor experiments. A total of 20 CLL samples (10 CLL-R and 10 CLL-S) were analyzed for H3K9me3 and H3K9ac. As shown in Figure 3 , although no significant difference (U-test, P40.5) was observed for the acetylated form of histone H3, we noted a significant increase (U-test, Po0.001) in H3K9me3 at the telomeres of CLL-R samples (50 ± 18% in CLL-R vs 14 ± 6% in CLL-S). As an internal control, we measured the density of H3 bound to telomeres of CLL cells, which was similar in sensitive and resistant cells. These results therefore show that telomeres of CLL-R cells are associated with an increase in the heterochromatic H3K9me3 mark, indicating a more compact telomeric chromatin configuration.
In conclusion, we report here that short telomeres occur in the restricted subset of CLL cells derived exclusively from patients refractory to front-line treatment with purine analogues and/or alkylating agents. This subset of CLL cells is characterized by their inability to activate apoptotic death following DNA damage in vitro. This feature is independent of IgV H mutational . (e) Comparison of average TRF1 and TRF2 protein level at the telomeric chromatin between CLL-S (light columns) and CLL-R (dark columns). Chromatin immunoprecipitations (ChIPs) were carried out as previously described 8 using polyclonal TRF1 and TRF2 antibodies (Santa Cruz Biotechnology, Santa Cruz, CA, USA). Immunoprecipitated DNA was extracted with phenol-chloroform-isoamylic alcohol and dot-spotted on Hybond N þ membrane (Amersham-Pharmacia Biotech, Orsay, France). Hybridization was in CHURCH buffer with a telomeric probe, g-32 P radiolabelled (TTAGGG) 10 oligonucleotide complementary to the double-strand part of telomeres. Membranes were exposed to Phosphoimager screen and signals were quantified by ImageQuant software (Amersham-Pharmacia Biotech). In each experiment, equal amounts of DNA (Quant-iT PicoGreen dsDNA Reagent from Molecular Probes, Invitrogen, Cergy-Pontoise, France) and identical immunoprecipitation conditions were used. DNA load was also controlled by hybridizing membranes with an Alu probe (5 0 -AAGTCGCGGCCGCTTGCAGTGAGCCGAGAT-3 0 ). The relative enrichment in telomeric DNA for each ChIP assays was calculated as follows: (telomeric signal of immunoprecipitated DNAÀtelomeric signal of no antibody control)/total telomeric signal (input). In all cases, the value obtained represents the percentage of the total input telomeric DNA (thus correcting for differences in the number of telomeric repeats) adjusted with respect to the amount of DNA used for each assay. To exclude unspecific binding between beads and crosslinked chromatin, a ChIP was performed in the absence of any antibody (No Ab). Input represents total DNA used in each ChIP assay. Quantification of the telomeric signals is shown in the right panel and is expressed as the mean percentage ± S.D. of the total telomeric DNA. A Mann-Whitney U-test was applied for statistical analysis and was considered as significant if P-value is o0.05.
status, but seems to be associated with multiple chromosomal abnormality, as well as with resistance to treatment (Table 1) . Moreover, we provide evidence of how these short telomeres are organized in chromatin context of resistant CLL cells. Mammalian telomeres are associated with both shelterin proteins and histones carrying heterochromatic modifications. Proper assembly of the six shelterin subunits and association with telomere sequences is crucial for telomere maintenance and control of telomerase activity. 2 Changes in the expression of shelterin genes have recently been established in CLL by comparison to normal B cells, suggesting a global telomere dysfunction in B-CLL. 5 However, despite enhanced telomere shortening, no evidence of altered shelterin protein expression or binding of TRF1 and TRF2 at telomeres was observed between sensitive and resistant CLL cells. These results indicate that if shelterin dysfunction occurs in CLL, it cannot alone explain the differences in telomere length between indolent and refractory forms of the disease. However, we found that telomeres of resistant cells were associated with elevated levels of histone lysine 9 trimethylation as compared with sensitive CLL cells. This histone modification mediates chromatin condensation. The elegant studies of Blasco 1 have shown that loss of heterochromatic histone modifications leads to abnormal telomere elongation, indicating that these histone modifications are negative regulators of telomere elongation. Our finding of elevated levels H3K9me3 at telomeres of resistant CLL implies aberrant epigenetic regulation in these malignant cells, leading to a more condensed telomeric structure. This may impair telomere elongation, perhaps by inhibiting the accessibility of telomerase or elongation factors in resistant cells, hence explaining the shorter telomeres despite similar telomerase expression in resistant and sensitive cells. We also investigate whether p53 deficiency or IgV H mutational status (Table 1) may be linked to short telomeres in resistant cells; an attractive hypothesis that would also explain the defect in apoptotic death signalling in these cells. However, CLL cells resistant to DNA damage-induced apoptosis have a similar proportion of p53wt and p53mut (reviewed in Bouley et al. 6 ) and unmutated and mutated IgV H genes, suggesting that multiple chromosomal aberrations, rather than p53 deficiency or lack of IgV H mutations, are associated with short telomeres in CLL-R. It remains to be determined whether the shorter heterochromatic telomeres found in resistant cells are the cause or the consequence of the resistance mechanisms operating in these cells. Nevertheless, our results suggest that heterochromatization of telomeres through increased H3K9me3 prevents telomere elongation, thus causing increased chromosomal instability, which was already observed in CLL cells showing short telomeres. 4 Ultimately, this might favour the entry of CLL cells into a short telomere-initiated senescence-like state, which could contribute to their maintenance. CLL cells may therefore be a paradigm for the role of telomeres in cancer, as short telomeres and high telomerase levels are often associated with poor clinical outcome in many types of cancer. As these cells exhibit a deregulated non homologous end joining (NHEJ) DNA repair (reviewed in Bouley et al. 6 ), this is reminiscent of the recent findings showing that mice with dysfunctional telomeres survive better with deficient DNA mismatch repair. 7 
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